• Non ci sono risultati.

CLINICAL FEATURES DIAGNOSTIC INVESTIGATIONS GENETICS/BASIC DEFECTS Hypochondroplasia

N/A
N/A
Protected

Academic year: 2022

Condividi "CLINICAL FEATURES DIAGNOSTIC INVESTIGATIONS GENETICS/BASIC DEFECTS Hypochondroplasia"

Copied!
4
0
0

Testo completo

(1)

517 Hypochondroplasia is a disproportionate short stature disor- der resembling achondroplasia but with less severe phenotype.

GENETICS/BASIC DEFECTS

1. Inheritance

a. Autosomal dominant with full penetrance b. Sporadic in 90% of cases

c. Observation of an increased paternal age effect at the time of conception, suggesting involvement of de novo mutations of paternal origin

d. Presence of locus heterogeneity

2. Evidence supporting the view that hypochondroplasia and achondroplasia are allelic disorders

a. A remarkable inter- and intra-familial variation in expression of hypochondroplasia with some cases resembling minor forms of achondroplasia

b. Offspring of an achondroplastic parent and hypochon- droplastic parent with severe neonatal achondroplasia resembling homozygous achondroplasia

c. Similar histopathological aspects of the growth carti- lage for the two disorders

3. Molecular defect

a. About 70% of affected individuals who are heterozy- gous for a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, which is mapped on chro- mosome 4p16.3

b. FGFR3 mutations reported

i. 1620C-A (Asn540Lys): 2/3rd of cases ii. 1620C-G (Asn540Lys): 1/3rd of cases

iii. 1658A-C (Asn540Thr) and other FGFR3 muta- tions: rare

4. Hypochondroplasia–achondroplasia compound heterozy- gote

a. Born to a hypochondroplastic parent and an achon- droplastic parent

b. The severity of the child: clinical and radiographic findings more severe than achondroplasia or hypochondroplasia alone

c. Demonstration of both the hypochondroplasia (Asn540Lys) and achondroplasia (Gly380Arg) muta- tions at the FGFR3 locus in a patient with the genetic compound

CLINICAL FEATURES

1. Short stature

a. Evident by school age b. Adult height: 128–165 cm 2. Stocky build

3. Facial appearance a. Usually normal

b. Mild macrocephaly may be present 4. Skeletal features

a. General features: usually similar but miler to achon- droplasia

b. Limbs

i. Disproportionately short compared with the length of the trunk

ii. Shortening of the proximal (rhizomelia) or mid- dle (mesomelia) segments of the extremities iii. Mild limitation of elbow extension

iv. Broad and short hands and feet (brachydactyly) v. Absence of trident hand deformity

vi. Bow legs (genu varum): usually mild vii. Adult onset osteoarthritis: less common c. Spine

i. Scoliosis

ii. Slight lumbar lordosis with a sacral tilt 5. Medical complication

a. Following complications: less frequent compared to achondroplasia

i. Spinal stenosis with neurologic complications ii. Tibial bowing

iii. Obstructive apnea

b. Deficits in mental capacity and/or function: may be more prevalent than achondroplasia

DIAGNOSTIC INVESTIGATIONS

1. Radiography

a. The most common features

i. Short proximal (rhizomelic) and/or middle (mesomelic) segments of the long bones with mild metaphyseal flare, especially femora and tibiae ii. Caudal narrowing or unchanged lumbar inter-

pedicular distance

iii. Mild to moderate brachydactyly iv. Short and broad femoral neck

v. Squared and shortened ilia

b. The less common but significant features i. Elongation of the distal fibula

ii. Anterior–posterior shortening of the lumbar ver- tebrae

iii. Dorsal concavity of the lumbar vertebral bodies iv. Shortening of the distal ulna

v. Long ulnar styloid in adults

vi. Prominence of muscle insertions on the long bones vii. Shallow “chevron” deformity of distal femur

metaphysis

viii. Low articulation of sacrum on pelvis with a hor- izontal orientation

ix. Flattened acetabular roof 2. Molecular genetic testing

a. Mutation analysis

i. 1620C-A (Asn540Lys) ii. 1620C-G (Asn540Lys) iii. Other FGFR3 mutations

Hypochondroplasia

(2)

518 HYPOCHONDROPLASIA

b. Sequence analysis of mutations in FGFR3 exons 10, 13, and 15

GENETIC COUNSELING

1. Recurrence risk

a. Patient’s sib: an extremely low risk (<0.01%) of hav- ing an affected sib if parents are not affected (germline mosaicism has not been reported for hypochondroplasia)

b. Patient’s offspring

i. 50% risk of having an affected offspring if the spouse is normal

ii. If the spouse is an achondroplastic

a) 25% chance of having an affected offspring with hypochondroplasia

b) 25% chance of having an affected offspring with achondroplasia

c) 25% chance of having an affected offspring with achondroplasia–hypochondroplasia gene- tic compound

d) 25% chance of having a normal offspring iii. If the spouse also has hypochondroplasia or other

dominant form of skeletal dysplasia: genetic counseling becoming more complicated due to the high incidence of genetic heterogeneity and the lack of medical literature addressing these circumstances

2. Prenatal diagnosis

a. Prenatal diagnosis by amniocentesis or CVS for fam- ily with high-risk pregnancy with a parent who has hypochondroplasia

i. When the spouse is normal: testing for disease- causing FGFR3 mutation in the fetus

ii. When the spouse is affected with another domi- nantly inherited skeletal dysplasia caused by a known gene mutation: testing for the known mutation for that skeletal dysplasia and the mutation for the hypochondroplasia in the fetus b. Prenatal diagnosis by ultrasonography, amniocentesis

or CVS in low-risk pregnancy without family history of affected individual

i. Ultrasonography: short limbs detected by routine ultrasound examination late in pregnancy ii. DNA-based diagnosis of FGFR3 mutations to

confirm the diagnosis of hypochondroplasia 3. Management

a. Follow closely developmental milestones and signs of learning disability or mental retardation

b. Treatment of short stature

i. Trials of growth hormone therapy with mixed results

ii. Surgical limb lengthening for severe case of hypochondroplasia

a) An invasive procedure

b) Entails considerable disability and discom- fort over a long period of time

c) Prefer postponement of the procedure until adolescence when the patient can make an informed decision

REFERENCES

Appan S, Laurent S, Chapman M, et al.: Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 79:796–803, 1990.

Beals RK: Hypochondroplasia. A report of five kindreds. J Bone Joint Surg Am 51:728–736, 1969.

Bellus GA, McIntosh I, Smith EA, et al.: A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochon- droplasia. Nat Genet 10:357–359, 1995.

Bellus GA, McIntosh I, Szabo J, et al.: Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene. Ann N Y Acad Sci 785:182–187, 1996.

Bellus GA, Kelly TE, Aylsworth AS: Hypochondroplasia. Gene Reviews, 2003.

http://www.genetests.org

Bonaventure J, Rousseau F, Legeai-Mallet L, et al.: Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achon- droplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet 63:148–154, 1996.

Chitayat D, Fernandez B, Gardner A, et al.: Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagno- sis and postnatal outcome. Am J Med Genet 84:401–405, 1999.

Cohen MM Jr: Achondroplasia, hypochondroplasia and thanatophoric dysplasia:

clinically related skeletal dysplasias that are also related at the molecular level. Int J Oral Maxillofac Surg 27:451–455, 1998.

Dorst JP: Hypochondroplasia. Birth Defects IV(5):260–276, 1969.

Flynn MA, Pauli RM: Double heterozygosity in bone growth disorders: four new observations and review. Am J Med Genet 121A:193–208, 2003.

Frydman M, Hertz M, Goodman RM: The genetic entity of hypochondroplasia.

Clin Genet 5:223–229, 1974.

Hall BD, Spranger J: Hypochondroplasia: clinical and radiological aspects in 39 cases. Radiology 133:95–100, 1979.

Huggins MJ, Mernagh JR, Steele L, et al.: Prenatal sonographic diagnosis of hypochondroplasia in a high-risk fetus. Am J Med Genet 87:226–229, 1999.

Huggins MJ, Smith JR, Chun K, et al.: Achondroplasia-hypochondroplasia complex in a newborn infant. Am J Med Genet 84:396–400, 1999.

Kozlowski K: Hypochondroplasia. Progr Pediatr Radiol 4:238–249, 1973.

Le Merrer M, Rousseau F, Legeai-Mallet L, et al.: A gene for achondroplasia- hypochondroplasia maps to chromosome 4p. Nat Genet 6:318–321, 1994.

Lemyre E, Azouz EM, Teebi AS, et al.: Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update. Can Assoc Radiol J 50:185–197, 1999.

McKusick VA, Kelly TE, Dorst JP: Observations suggesting allelism of the achondroplasia and hypochondroplasia genes. J Med Genet 10:11–16, 1973.

Mortier G, Nuytinck L, Craen M, et al.: Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. J Med Genet 37:220–224, 2000.

Newman DE, Dunbar JC: Hypochondroplasia. J Can Assoc Radiol 26:95–103, 1975.

Prinos P, Costa T, Sommer A, et al.: A common FGFR3 gene mutation in hypochondroplasia. Hum Mol Genet 4:2097–2101, 1995.

Prinster C, Carrera P, Del Maschio M, et al.: Comparison of clinical-radiological and molecular findings in hypochondroplasia. Am J Med Genet 75:

109–112, 1998.

Ramaswami U, Hindmarsh PC, Brook CG: Growth hormone therapy in hypochondroplasia. Acta Paediatr Suppl 88:116–117, 1999.

Ramaswami U, Rumsby G, Hindmarsh PC, et al.: Genotype and phenotype in hypochondroplasia. J Pediatr 133:99–102, 1998.

Rousseau F, Bonaventure J, Legeai-Mallet L, et al.: Clinical and genetic hetero- geneity of hypochondroplasia. J Med Genet 33:749–752, 1996.

Scott CI Jr: Achondroplastic and hypochondroplastic dwarfism. Clin Orthop Rel Res 114:18–30, 1976.

Sommer A, Young-Wee T, Frye T: Achondroplasia-hypochondroplasia com- plex. Am J Med Genet 26:949–957, 1987.

Tanaka N, Katsumata N, Horikawa R, et al.: The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia. Endocr J 50:69–75, 2003.

Wynne-Davies R, Patton MA: The frequency of mental retardation in hypochondroplasia [letter]. J Med Genet 28:644, 1991.

Wynne-Davies R, Walsh WK, Gormley J: Achondroplasia and hypochon- droplasia. Clinical variation and spinal stenosis. J Bone Joint Surg Br 63B:508–515, 1981.

(3)

HYPOCHONDROPLASIA 519

Fig. 1. A young child affected with hypochondroplasia showing mild short stature and mild rhizomelic shortening of the extremities.

(4)

520 HYPOCHONDROPLASIA

Fig. 2. Three families with familial hypochondroplasia showing stocky build, mild short stature, normal facial appearance, rhizomelic shortening of the extremities, and absence of trident hands.

Fig. 3. Radiographs of two patients with hypochondroplasia showing unchanged interpedicular distance and mild shortening of long bones.

Riferimenti

Documenti correlati

Pinette MG, Pan Y, Pinette SG, et al.: Gastroschisis followed by absorption of the small bowel and closure of the abdominal wall defect.. J Ultrasound Med

A low recurrence risk of having a male sib with hemophilia A if the mother has a normal factor VIII clotting activity and no evidence of her car- rying her son’s FVIII

Missense mutations in the TNSALP gene have been observed in some hypophosphatasia kindreds, partic- ularly those families with the more severe perinatal and infantile forms of

Dunwoodie SL, Clements M, Duncan S, et al.: Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene DLL3 are associated with disruption of the

Achondrogenesis type I was further subdivided, on the basis of convincing histo- logical criteria, into type IA, which has apparently normal car- tilage matrix but inclusions

Nicolaides KH, Snijders RJM, Chen HH, et al.: Fetal gastrointestinal and abdominal wall defects: Associated malformations and chromosomal abnormalities. Fetal Diagn Ther

somal recessive i. Autosomal recessive ii. Basic defects: absence or defective function of osteoclasts results in defective remodeling of bone with partial or complete obliteration

Jansen T, Romiti R: Progeria infantum (Hutchinson-Gilford syndrome) associ- ated with scleroderma-like lesions and acro-osteolysis: a case report and brief review of the literature..